Death, Sudden, Cardiac
58
3
6
43
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.7%
1 terminated out of 58 trials
97.7%
+11.2% vs benchmark
19%
11 trials in Phase 3/4
19%
8 of 43 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 43 completed trials
Clinical Trials (58)
Cardiac Magnetic Resonance-Clinical Prediction Model-Dilated Cardiomyopathy
PRE-hospital Cooling to improvE carDiac arrEst Neurological outComEs (PRECEDENCE)
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
Genetic Determinants of Sudden Cardiac Death
Pre-hospital ECMO in Advanced Resuscitation in Patients With Refractory Cardiac Arrest. ( SUB30 )
DISCOVERY: Diagnostic Data and Genetic Polymorphisms in ICD Patients.
An Educational Program to Improve Cardiac Arrest Diagnostic Accuracy of Ambulance Telecommunicators
Risk of Sudden Cardiac Death in UN Athletes
Magnetocardiography (MCG) Parameters in the Prediction of Future ICD Therapy
ASSURE WCD Clinical Evaluation - Conversion Efficacy Study
Genomics of Sudden Cardiac Arrest
Blood Management During ECMO for Cardiac Support
Is the Perfusion Index an Accurate Predictor of Return of Spontaneus Circulation in Out-of-hospital Cardiac Arrest
ECPR for Refractory Out-Of-Hospital Cardiac Arrest
Epidemiology of Long QTand Asian Sudden Death in Sleep
Monitoring of Arrhythmias in Patients Treated With Antipsychotics
Drug-Induced Sudden Death & Ventricular Arrhythmia
PREVENTION-ACHD Risk Score
Drug-induced Repolarization ECG Changes
Decision Support for Adults Facing Implantable Cardioverter-Defibrillator Pulse Generator Replacement